Clinical Trial Update: A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the safe-use conditions for home administration of ZULRESSO (brexanolone) in postpartum depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• Zulresso (brexanolone)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Postpartum Depression | Phase 4 | Status: COMPLETED | Results posted: 2023-07-19